The Texas State Board of Pharmacy is pleased to partner with the Drug Enforcement Administration (DEA) Dallas Field Division to bring this pharmacy-oriented continuing education program to Texas pharmacy professionals. The symposium offers three (3) hours (0.3 CEUs) of CE approved by the Texas State Board of Pharmacy for license renewal. This program may be counted toward the requirement of prescribing and monitoring controlled substances as outlined by Board rule 295.8 for pharmacists and toward Texas-specific pharmacy laws or rules for pharmacy technicians per Board rule 297.8.
For more details regarding this program, visit our FAQ page.
Virtual Pharmacist Opioid Symposium
"The Opioid Epidemic and the Practice of Pharmacy" — Lisa D. Sullivan
"Pharmacist Analysis of Drug Diversion" — Diane B. Ginsburg
"Texas Prescription Monitoring Program" — Terri Burrows
This program will be offered twice to allow for attendee schedules, as follows:
Sunday, June 13, 2021 & Monday, June 14, 2021
9am to 12pm CST both days
If you'd like to attend, you only need to register for one of the sessions. Pharmacists and pharmacy technicians who wish to attend both days to view the program twice may do so, but this requires two separate registrations and payments. Credit may only be claimed for one of the sessions attended, as a program may only be counted once toward license renewal in a single license period.
Lisa D. Sullivan | Bio
Diversion Program Manager
DEA Dallas Field Division
Diane B. Ginsburg, Ph.D., M.S., R.Ph., FASHP | Bio
Clinical Professor, Pharmacy Practice Division
Associate Dean for Healthcare Partnerships
G.D. Searle Endowed Fellow in Pharmacy
The University of Texas at Austin College of Pharmacy
Adjunct Instructor, DEA Training Academy
Terri Burrows, R.Ph., Pharm.D. | Bio
Compliance Officer, Region 8 Dallas
Texas State Board of Pharmacy